Treatment effectiveness of venetoclax-based therapy after Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: An International Real-World Study Research Letter
| Authors: | Ghosh, N.; Eyre, T. A.; Brown, J. R.; Lamanna, N.; Manzoor, B. S.; Coombs, C. C.; Tuncer, H. H.; Ujjani, C.; Leslie, L. A.; Roeker, L. E.; Davids, M. S.; Rhodes, J. M.; Skarbnik, A. P.; Sinai, W.; Fleury, I.; Hill, B. T.; Martinez-Calle, N.; Barr, P. M.; Jawaid, D.; Emechebe, N.; Pearson, L.; Lansigan, F.; Choi, Y.; Jensen, C. E.; Fakhri, B.; Stephens, D. M.; Marx, S. E.; Schuster, S. J.; Coyle, M.; Pivneva, I.; Watson, T.; Guerin, A.; Shadman, M. |
| Title: | Treatment effectiveness of venetoclax-based therapy after Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: An International Real-World Study |
| Keywords: | treatment response; drug efficacy; drug safety; rituximab; follow up; letter; progression free survival; protein p53; drug therapy; chronic lymphatic leukemia; therapy; chronic lymphocytic leukemia; clinical outcome; human; male; female; obinutuzumab; venetoclax; bruton tyrosine kinase inhibitor; real-world outcomes |
| Journal Title: | American Journal of Hematology |
| Volume: | 100 |
| Issue: | 3 |
| ISSN: | 0361-8609 |
| Publisher: | John Wiley & Sons, Inc. |
| Date Published: | 2025-03-01 |
| Start Page: | 511 |
| End Page: | 515 |
| Language: | English |
| DOI: | 10.1002/ajh.27563 |
| PUBMED: | 39698781 |
| PROVIDER: | scopus |
| PMCID: | PMC11803543 |
| DOI/URL: | |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Source: Scopus |
